Peripherally acting u-opioid receptor antagonists as treatment opti | PPA
PDF) Opioids in COVID-19: Two Sides of a Coin
Antidepressant-like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors | Neuropsychopharmacology
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect
Peripheral acting Mu opioid receptor antagonists in the treatment of the opioid-induced constipation: review
Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect
Peripheral acting Mu opioid receptor antagonists in the treatment of the opioid-induced constipation: review
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect
Methylnaltrexone Mechanisms of Action and Effects on Opioid Bowel Dysfunction and Other Opioid Adverse Effects - Chun-Su Yuan, 2007
Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches | Molecular Psychiatry
Major Depressive Disorder and Kappa Opioid Receptor
Pharmaceuticals | Free Full-Text | Opioid Analgesia and Opioid-Induced Adverse Effects: A Review
IJMS | Free Full-Text | Tissue Regeneration: The Dark Side of Opioids
Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches | Molecular Psychiatry
Pharmacology of Opioids: What Practitioners Need to Know
Data-driven analysis of kappa opioid receptor binding in major depressive disorder measured by positron emission tomography | Translational Psychiatry
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Kappa Opioid Receptors in the Pathology and Treatment of Major Depressive Disorder | SpringerLink
